Ülrike Sommer

ORCID: 0009-0002-6698-0884
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Ancient and Medieval Archaeology Studies
  • Historical and Archaeological Studies
  • Parkinson's Disease Mechanisms and Treatments
  • Archaeology and ancient environmental studies
  • European history and politics
  • Cytokine Signaling Pathways and Interactions
  • Archaeological Research and Protection
  • Bone Metabolism and Diseases
  • Neurological disorders and treatments
  • Bone health and treatments
  • Bone health and osteoporosis research
  • Historical and Cultural Archaeology Studies
  • Historical Geopolitical and Social Dynamics
  • Pleistocene-Era Hominins and Archaeology
  • Orthopaedic implants and arthroplasty
  • Biochemical Analysis and Sensing Techniques
  • German Literature and Culture Studies
  • Taxation and Legal Issues
  • Orthopedic Infections and Treatments
  • Law and Political Science
  • Estrogen and related hormone effects
  • Olfactory and Sensory Function Studies
  • Cultural Heritage Management and Preservation
  • Central European national history
  • Pharmacological Effects of Natural Compounds

Novartis (Switzerland)
2015-2025

Heidelberg University
2003-2024

University Hospital Heidelberg
1994-2024

University College London
2008-2024

Museum of London Archaeology
2013-2023

Novartis Institutes for BioMedical Research
2015

University Hospital Carl Gustav Carus
2012

TU Dresden
2000-2012

UCL Australia
2007

Heidelberg University
2007

Recent studies support the idea of olfactory dysfunction as a very early sign idiopathic Parkinson's disease (IPD). Aim present study was to clinically follow-up patients with hyposmia find out percentage developing IPD after 4 years time. At baseline, tests had been combined transcranial sonography substantia nigra and 123I-FP-CIT SPECT imaging. neurological examination, 7% individuals developed clinical IPD. Altogether, 13% presented abnormalities motor system. Our data suggest that...

10.1002/mds.21413 article EN Movement Disorders 2007-03-13

The response of psoriasis to antibodies targeting the interleukin (IL)-23/IL-17A pathway suggests a prominent role T-helper type-17 (Th17) cells in this disease. We examined clinical and immunological patterns 100 subjects with moderate-to-severe receiving 3 different intravenous dosing regimens anti-IL-17A antibody secukinumab (1 × mg/kg or 1 10 on Day 1, Days 15 29) placebo phase 2 trial. Baseline biopsies revealed typical features active psoriasis, including epidermal accumulation...

10.1111/exd.12710 article EN cc-by Experimental Dermatology 2015-04-02

Abstract Olfactory loss is among the early signs of Parkinson's disease (PD). We investigated whether “idiopathic” olfactory dysfunction might relate to nigral degeneration. tests were combined with transcranial sonography substantia nigra and single photon emission computed tomography (SPECT) imaging. Thirty patients diagnosed idiopathic participated. Eleven these exhibited an increased echogenicity SN in sonography. In 10 11 patients, SPECT scans 123 I‐FP‐CIT performed. Median uptake...

10.1002/mds.20141 article EN Movement Disorders 2004-05-13

Abstract This study investigates the effects of kyphoplasty on pain and mobility in patients with osteoporosis painful vertebral fractures compared conventional medical management. Introduction: Pharmacological treatment primary does not prevent impaired activity fractures. Therefore, we evaluated clinical outcome after associated chronic for >12 months. Materials Methods: Sixty presenting months were included this prospective, nonrandomized controlled study. Twenty-four hours before...

10.1359/jbmr.041203 article EN Journal of Bone and Mineral Research 2005-04-01
Ildikó Madurka Alexander Vishnevsky Joan B. Soriano Stephanus J. Gans Danilo Joel Salazar Ore and 95 more Adrián Rendón Charlotte Suppli Ulrik Sushma Bhatnagar Srikanth V. Krishnamurthy Kirsten Mc Harry Tobias Welte Alberto Alfredo Fernandez Beata Mehes Karin Meiser Ewa Gatlik Ülrike Sommer G. Junge Ederlon Rezende Alberto Alfredo Fernandez Ana Maria Bagu Florencia Heredia Amido Maria Belen Costa Jorge Alejandro Brigante Gaston Franco Nadia Ahmed Natalia Zerega Marcelo Rodrigues Bacci Caio César Ferreira Fernandes Henrique Gitti Ragognete Ederlon Rezende Caio Vinicius Gouvêa Jaoude Ellen Pierre de Olivera Vania Quinato Malacize Claudio Stadnik Eduarda Annoni Ramos Graziela Regina Kist Gynara Rezende Barbosa Henrique Filik Sabrina Nalin Charlotte Suppli Ulrik Casper Tidemandsen Kjell Erik Julius Håkansson Thomas Benfield Karen Brorup Pedersen Tobias Welte Marcus Bachman Mathias Stoll Ilona Olzik Natascha Scharf Nicole Shearman Isabell Pink Anna Frey Petra Schulze Cyrus Sayehli Dirk Weismann Hartwig Klinker Maria-Elisabeth Goebeler Lars S. Maier Florian Geismann Frank Hanses Judith Zeller Julian Hupf Matthias Lubnow Sabine Sag Sarah Ripfel Steffen Pabel Stilla Bauernfeind Ulf Leisner Florian Hitzenbichler Ildikó Madurka Dora Iharos Krisztina Kormosoi Toth Maria Hejja Tamas Esze Sushma Bhatnagar Anant Mohan Anuja Pandit Balbir Kumar Brajesh Kumar Ratre Pawan Tiwari Ram Singh Saurabh Vig Shweta Bhopale S. Bhan Akshay Budhraja Ankit Agrawal Srikanth V. Krishnamurthy Ambika Srikanth Kalaiyamishan Kaneesan Mauila Raghavan Jaymohan Unnithan Nagarajan Srinivasan Nandagopal Velayuthaswamy Senthil Kumar Mothu Gounder Venkatraman Vaidyanathan Amitabha Saha Abhishek Bhattacharjee Avijatri Datta Adrián Rendón Adrián Camacho Ortiz Berenice Soto-Monciváis

10.1007/s15010-022-01904-w article EN Infection 2022-09-14

Abstract This first‐in‐human study evaluated the safety, tolerability, single‐ and multiple‐dose pharmacokinetic profiles with dietary influence, pharmacodynamics (PD) of DFV890, an oral NLRP3 inhibitor, in healthy participants. In total, 122 participants were enrolled into a three‐part trial including single 2‐week multiple ascending doses (SAD MAD, respectively) randomized (3:1) to DFV890 or placebo [3–600 mg] MAD [fasted: 10–200 mg, once‐daily fed: 25 50 twice‐daily]). was generally...

10.1111/cts.13789 article EN cc-by-nc-nd Clinical and Translational Science 2024-05-01

Antibiotic-loaded PMMA bone cement is frequently used in modern trauma and orthopedic surgery. Although many of the antibiotics routinely applied are described to have cytotoxic effects literature, clinical experience shows no adverse for healing. To determine antibiotic-loaded spacers on osteogenesis vitro, we cultivated human marrow mesenchymal stem cells (BM-hMSCs) presence containing Gentamicin, Vancomycin, Gentamicin + Clindamycin as well Vancomycin addition a blank control (agarose)...

10.3390/antibiotics13010044 article EN cc-by Antibiotics 2024-01-03

The suppressors of cytokine signaling (SOCS) are negative feedback inhibitors and growth factor-induced signal transduction. C-terminal SOCS box region is thought to regulate protein stability most likely via an elongin C interaction. In the present study, we have found that phosphorylation SOCS3 at two tyrosine residues in conserved box, Tyr204 Tyr221, can inhibit SOCS3-elongin interaction activate proteasome-mediated degradation. Jak-mediated decreased half-life, both Tyr221 was required...

10.1074/jbc.m303170200 article EN cc-by Journal of Biological Chemistry 2003-08-01

Angiogenesis is indispensable during fracture repair, and vascular endothelial growth factor (VEGF) critical in this process. CCN1 (CYR61) an extracellular matrix signaling molecule that has been implicated neovascularization through its interactions with several integrin receptors. shown to be up-regulated the reparative phase of healing; however, role therein remains unclear. Here, regulation expression osteoblasts functional consequences thereof were studied. Stimulation VEGF resulted a...

10.1074/jbc.m705200200 article EN cc-by Journal of Biological Chemistry 2007-07-12

Persistent activation of the transcription factor STAT3 has been detected in many types cancer and plays an important role tumor progression, immune evasion metastasis. To analyze persistent we coexpressed with v-Src. We found that tyrosine phosphorylation by v-Src is independent Janus kinases (Jaks), canonical activators STATs. The STAT3-induced feedback inhibitor, suppressor cytokine signaling 3 (SOCS3), did not interfere However, protein inhibitor activated (PIAS3) suppressed gene...

10.1242/jcs.03482 article EN Journal of Cell Science 2007-08-29

Abstract Background Calcium phosphate cements are used frequently in orthopedic and dental surgeries. Strontium-containing drugs serve as systemic osteoblast-activating medication various clinical settings promoting mechanical stability of the osteoporotic bone. Methods calcium cement (SPC) (CPC) were compared regarding their local effects on bone tissue a standard animal model for A defect was created distal femoral metaphysis 60 ovariectomized Sprague-Dawley rats. CPC SPC to fill defects...

10.1186/1749-799x-8-16 article EN cc-by Journal of Orthopaedic Surgery and Research 2013-06-07

Inflammatory bowel disease (IBD) consists of chronic conditions that severely impact a patient's health and quality life. Interleukin-10 (IL-10), potent anti-inflammatory cytokine has strong genetic links to IBD susceptibility shown efficacy in rodent models, suggesting it great therapeutic potential. However, when tested clinical trials for IBD, recombinant human IL-10 (rhIL-10) showed weak inconsistent due its short half-life pro-inflammatory properties counteract the efficacy. Here we...

10.1016/j.str.2024.12.010 article EN cc-by-nc-nd Structure 2025-01-01

This article comprises a brief report on the 2023 excavations of an extensive Eneolithic cemetery undertaken as UCL collaboration with colleagues from Muzeul Județean Satu Mare.The site represents largest Middle Bodrogkeresztúr culture in Romania and has yielded grave finds, including items gold copper.

10.14324/ai.27.1.17 article EN cc-by Archaeology International 2025-01-20

Abstract The current consensus recommendation papers dealing with the unique requirements for analytical validation of assays performed by flow cytometry address sensitivity (both and functional) only in general terms. In this paper, a detailed approach designing validating rare event methods is described. impact panel design optimization on lower limit quantification (LLOQ) suggestions reporting data near, or below, LLOQ are addressed. This paper serves to provide best practices...

10.1002/cyto.b.21949 article EN Cytometry Part B Clinical Cytometry 2020-09-17

Abstract Background This retrospective study of 73 myeloma patients with painful vertebral lesions compares clinical and radiomorphological outcomes up to 2 years after additional kyphoplasty, radiation therapy or systemic treatment only. Methods We assessed pain, disability parameters by visual analogue scale (VAS 0‐100), Oswestry Disability Index re‐evaluating available follow‐up X‐rays, respectively, in that were treated according a pathway. Results After the VAS score was reduced all...

10.1002/jso.22101 article EN Journal of Surgical Oncology 2011-09-29

The 14th edition of the Workshop on Recent Issues in Bioanalysis (14th WRIB) was held virtually June 15-29, 2020 with an attendance over 1000 representatives from pharmaceutical/biopharmaceutical companies, biotechnology contract research organizations, and regulatory agencies worldwide. WRIB included three Main Workshops, seven Specialized Workshops that together spanned 11 days order to allow exhaustive thorough coverage all major issues bioanalysis, biomarkers, immunogenicity, gene...

10.4155/bio-2021-0005 article EN Bioanalysis 2021-01-29

The 15th edition of the Workshop on Recent Issues in Bioanalysis (15th WRIB) was held 27 September to 1 October 2021. Even with a last-minute move from in-person virtual, an overwhelmingly high number nearly 900 professionals representing pharma and biotech companies, contract research organizations (CROs), multiple regulatory agencies still eagerly convened actively discuss most current topics interest bioanalysis. WRIB included three Main Workshops seven Specialized that together spanned...

10.4155/bio-2022-0080 article EN Bioanalysis 2022-05-01

Signal transducer and activator of transcription 3 (STAT3) is a factor that involved in variety biological functions. It essential for the signal transduction interleukin-6 (IL-6) related cytokines. In response to IL-6 stimulation STAT3 becomes phosphorylated translocates into nucleus where it binds enhancer sequences target genes. We found activated enriched dot-like structures within nucleus, which we termed nuclear bodies. To examine dynamics body formation, fusion protein yellow...

10.1242/jcs.00833 article EN Journal of Cell Science 2003-12-09

Interleukin-6 (IL-6) is a potent stimulator of bone resorption which has been demonstrated in variety vivo and vitro models. We investigated the regulation IL-6 secretion primary human osteoblastic cells (HOC) by cytokines known to play an important role coupling formation resorption. HOC were isolated from healthy adults who underwent selective orthopedic surgery treated with released microenvironment during i.e Interleukin-1 β (IL-lβ), Tumor Necrosis Factor (TNFa), Transforming Growth 1 2...

10.1055/s-0029-1211993 article EN Experimental and Clinical Endocrinology & Diabetes 2009-07-14
Coming Soon ...